Search
for
Sort by
Research 151–180 of 1000+
- Hormone Blocking Anticancer Drugs
- Roles of tumor suppressors in regulating tumor-associated inflammation
- Ruxolitinib for the treatment of severe alopecia areata
- Modern Management Approaches for Alopecia Areata
- The PDGF/PDGFR pathway as a drug target
- Targeting the Wnt pathways for therapies
- Ethanol Enhances Neurosteroidogenesis in Hippocampal Pyramidal Neurons by Paradoxical NMDA Receptor Activation
- An accessible pharmacodynamic transcriptional biomarker for notch target engagement
- Migration Inhibitory Factor in Conditioned Medium from Human Umbilical Cord Blood-Derived Mesenchymal Stromal Cells Stimulates Hair Growth
- Clinical management of cutaneous adverse events in patients on targeted anticancer therapies and immunotherapies: a national consensus statement by the Spanish Academy of Dermatology and Venereology and the Spanish Society of Medical Oncology
- The concealed side of caspases: beyond a killer of cells
- Dermatologic adverse events associated with chemotherapy and targeted anticancer therapy
- Immune Microenvironment of Hair Follicles in Tumor Immunotherapy
- Steroid Hormones
- Hormone therapy in acne
- The Current Status of the Pharmaceutical Potential of Juniperus L. Metabolites
- Alopecia Areata: a Comprehensive Review of Pathogenesis and Management
- The role of lymphocytes in the development and treatment of alopecia areata
- Hair Supplements
- Toxic Side Effects of Targeted Therapies and Immunotherapies Affecting the Skin, Oral Mucosa, Hair, and Nails
- Integrated single-cell chromatin and transcriptomic analyses of peripheral immune cells in patients with alopecia areata
- Long-Term Response of Hirsutism and Other Hyperandrogenic Symptoms to Combination Therapy in Polycystic Ovary Syndrome
- Hair Follicle Disruption Facilitates Pathogenesis to UVB-Induced Cutaneous Inflammation and Basal Cell Carcinoma Development in Ptch+/− Mice
- An overview of management of drug-induced hair and nail disorders
- Real-World Safety Profile of Generic Palbociclib in Hormone Receptor–Positive, HER2-Negative Metastatic Breast Cancer: A Prospective Observational Study in Iraq”
- Dermatologic Comorbidities Associated with Atopic Dermatitis Towards a Shared Therapeutical Approach: A Narrative Review
- Results of clinical examinations, laboratory tests, and ultrasonography in dogs with pituitary-dependent hyperadrenocorticism treated with trilostane
- Dermatologic Adverse Events from Cancer Treatments
- The role of protein lactylation in skin diseases: from molecular mechanisms to potential therapeutics
- Steroid Sulfatase: Molecular Biology, Regulation, and Inhibition